Table 4.
ILTS transplant oncology consensus conference (74) | Grade of recommendation | Recommendations by the Spanish Society of Liver Transplantation (73) | Grade of recommendation |
---|---|---|---|
LT can be a viable option in highly selected patients with unresectable CRLM with only liver involvement | moderate evidence and moderate recommendation | In selected patients with unresectable liver metastases of colorectal cancer, LT could be considered only in the context of well-designed clinical trials and after a close evaluation by a multidisciplinary team composed by oncologists, hepatologists, and surgeons. | 2B |
LT for CRLM with low Oslo score ≤2 may improve the 5-year OS rates over those achieved with the current standard of care | moderate evidence and moderate recommendation | The optimal strategy for waiting list prioritization is not established and should be tailored according to the composition and length of the waiting list in each region. | 2C |
Minimization of immunosuppression is recommended | low evidence and moderate recommendation | The type of donor would be at the discretion of each transplant center according to local experience and length of stay in the waiting list. | 2C |
Aggressive treatment of all post-LT resectable recurrences is recommended | low evidence and moderate recommendation | ||
There is a need for an international registry to coordinate data collection and design further studies on LT for CRLM | moderate evidence and moderate recommendation |
CRLM, Colon Rectal Liver Metastases; LT, Liver Transplantation; OS, Overall Survival.